Sustained Renal Response to Mycophenolate Mofetil and CNI Taper Promotes Survival in Liver Transplant Patients with CNI-Related Renal Dysfunction

被引：0
|
作者：
A. Kornberg
B. Küpper
K. Thrum
B. Krause
P. Büchler
J. Kornberg
A. Sappler
A. Altendorf-Hofmann
J. Wilberg
H. Friess
机构：
[1] TU Munich,Department of Surgery, Klinikum Rechts der Isar
[2] Zentralklinikum Bad Berka,Department of Surgery
[3] FSU Jena,Department of General, Visceral and Vascular Surgery
来源：
Digestive Diseases and Sciences | 2011年 / 56卷
关键词：
Liver transplantation; Mycophenolate mofetil; Calcineurin inhibitor; Renal function; Long-term survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：244 / 251
页数：7
相关论文
共 50 条
  • [1] Sustained Renal Response to Mycophenolate Mofetil and CNI Taper Promotes Survival in Liver Transplant Patients with CNI-Related Renal Dysfunction
    Kornberg, A.
    Kuepper, B.
    Thrum, K.
    Krause, B.
    Buechler, P.
    Kornberg, J.
    Sappler, A.
    Altendorf-Hofmann, A.
    Wilberg, J.
    Friess, H.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (01) : 244 - 251
  • [2] SUSTAINED RENAL IMPROVEMENT TO MMF AND CNI TAPER PROMOTES LONG-TERM SURVIVAL IN LIVER TRANSPLANT PATIENTS WITH CNI-RELATED NEPHROPATHY
    Kornberg, A.
    Thrum, K.
    Kuepper, B.
    Krause, B.
    Buechler, P.
    Altendorf-Hofmann, A.
    Friess, H.
    Wilberg, J.
    [J]. TRANSPLANT INTERNATIONAL, 2010, 23 : 47 - 47
  • [3] A randomised controlled trial of calcineurin inhibitor (CNI) replacement with mycophenolate mofetil and steroids in liver transplant patients with renal dysfunction.
    Day, CP
    O'Grady, J
    Mayer, D
    Simpson, K
    Millson, CE
    Solomons, N
    Duncan, J
    Bechter, M
    Patch, D
    [J]. HEPATOLOGY, 2004, 40 (04) : 547A - 547A
  • [4] Reduced-dosed CNI plus Sirolimus for CNI-related Chronic Renal Dysfunction after Heart Transplantation
    Yin, D.
    Huang, J.
    Feng, L.
    Liao, Z. K.
    [J]. CARDIOLOGY, 2009, 114 : 43 - 44
  • [5] Evolution of chronic renal dysfunction after conversion from calcineurin inhibitors (CNI) to mycophenolate mofetil monotherapy in liver transplant recipients
    Manrique, Alejandro
    Jimenez, Carlos
    Ortega, Patricia
    Abradelo, Manuel
    Meneu, Juan C.
    Gimeno, Alberto
    Perez, Baltasar
    Calvo, Jorge
    Donat, Maria
    Cambra, Felix
    Lopez, Rose M.
    Morales, Jose M.
    Moreno, Enrique
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 32 - 32
  • [6] RENAL IMPROVEMENT AFTER CONVERSION TO MMF PREDICTS LONG-TERM SURVIVAL IN LIVER TRANSPLANT PATIENTS WITH CNI-RELATED NEPHROPATHY.
    Kornberg, Arno
    Kuepper, Bernadett
    Thrum, Katharina
    Habrecht, Olaf
    Sappler, Annette
    [J]. LIVER TRANSPLANTATION, 2009, 15 (07) : S245 - S245
  • [7] Renal Dysfunction After Liver Transplant: Is CNI Nephrotoxicity Overrated
    Puri, Pankaj
    Bansal, Nalini
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 13 (04) : 556 - 558
  • [8] CNI-Related Renal Impairment in Liver Transplantation: A Comparison of Cyclosporine and Tacrolimus-Based Regimens
    Davie, A.
    Damera, V.
    Bianic, F.
    Ricci, J.
    Bernhardt, P.
    Gokhale, S.
    Lake, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 533 - 533
  • [9] LONG TERM OUTCOME OF CNI WITHDRAWAL FOR POST LIVER TRANSPLANT RENAL DYSFUNCTION
    Mackay, Jamie
    Angus, Peter W.
    Gow, Paul
    [J]. HEPATOLOGY, 2008, 48 (04) : 563A - 563A
  • [10] Mycophenolate mofetil (MMF) in combination with calcineurin inhibitors (CNI) for chronic renal dysfunction after liver transplantation: A prospective, randomized study
    Pageaux, GP
    Vercambre, L
    Rostaing, L
    Duvoux, C
    Calmus, Y
    Vanlemmens, C
    Botta, D
    Bernard, PH
    Bismuth, M
    Jacquet, E
    Navarro, E
    Larrey, D
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 : 57 - 57
12345